Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies
/PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic...
prnewswire.com